Azar Taps Nat’l Cancer Institute Director As Acting FDA Commissioner

National Cancer Institute Director Ned Sharpless will become acting commissioner of FDA when current Commissioner Scott Gottlieb resigns in early April, HHS Secretary Alex Azar announced at a House hearing Tuesday (March 12). Sharpless was among three candidates viewed as top contenders for the job, and Azar said Sharpless’ “deep scientific background and expertise will make him a strong leader for FDA,” he said. “There will be no let-up in the agency’s focus, from ongoing efforts on drug approvals and...